In our earlier preclinical studies, we reported that apigenin depleted immunosuppressive MDSC and TAM from the TME, induced SHIP-1 expression, increased tumoricidal macrophages, enhanced anti-tumor immune responses and reduced tumor burden in different PC models [12]. Here, INPP5D is linked to neoplasm.